<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28119500</article-id>
<article-id pub-id-type="pmc">5307446</article-id>
<article-id pub-id-type="publisher-id">201611089</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1611089114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome</article-title>
<alt-title alt-title-type="short">NCS-1/Ric8a complex inhibitors regulate synapses</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mansilla</surname>
<given-names>Alicia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chaves-Sanjuan</surname>
<given-names>Antonio</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Campillo</surname>
<given-names>Nuria E.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Semelidou</surname>
<given-names>Ourania</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martínez-González</surname>
<given-names>Loreto</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Infantes</surname>
<given-names>Lourdes</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>González-Rubio</surname>
<given-names>Juana María</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gil</surname>
<given-names>Carmen</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Conde</surname>
<given-names>Santiago</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Skoulakis</surname>
<given-names>Efthimios M. C.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferrús</surname>
<given-names>Alberto</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martínez</surname>
<given-names>Ana</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sánchez-Barrena</surname>
<given-names>María José</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Departamento de Neurobiología del Desarrollo, Instituto Cajal, <institution>Spanish National Research Council</institution>, 28002 Madrid, <country>Spain</country>;</aff>
<aff id="aff2"><sup>b</sup>Departamento de Cristalografía y Biología Estructural, Instituto de Química Física Rocasolano, <institution>Spanish National Research Council</institution>, 28006 Madrid, <country>Spain</country>;</aff>
<aff id="aff3"><sup>c</sup>Centro de Investigaciones Biológicas, <institution>Spanish National Research Council</institution>, 28040 Madrid, <country>Spain</country>;</aff>
<aff id="aff4"><sup>d</sup>Division of Neuroscience, <institution>Biomedical Sciences Research Centre Alexander Fleming</institution>, 16672 Vari, <country>Greece</country>;</aff>
<aff id="aff5"><sup>e</sup>Instituto de Química Médica, <institution>Spanish National Research Council</institution>, 28006 Madrid, <country>Spain</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>2</sup>To whom correspondence should be addressed. Email: <email>xmjose@iqfr.csic.es</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Gregory A. Petsko, Weill Cornell Medical College, New York, NY, and approved December 23, 2016 (received for review July 7, 2016)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: A. Mansilla, N.E.C., O.S., C.G., E.M.C.S., A.F., A. Martínez, and M.J.S.-B. designed research; A. Mansilla, A.C.-S., N.E.C., O.S., L.M.-G., L.I., J.M.G.-R., C.G., E.M.C.S., A. Martínez, and M.J.S.-B. performed research; S.C. contributed new reagents/analytic tools; A.F., A. Martínez, and M.J.S.-B. analyzed data; and A.F. and M.J.S.-B. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="fn1">
<p><sup>1</sup>A. Mansilla and A.C.-S. contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p>Conflict of interest statement: The Spanish National Research Council has filed a patent application (P201531358) with the Spanish Patent Office on the use of FD44 and derivatives as regulators of synaptopathies. A. Mansilla, N.E.C., C.G., A.F., A. Martínez, and M.J.S.-B. are listed as inventors.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>7</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>1</month>
<year>2017</year>
</pub-date>
<volume>114</volume>
<issue>6</issue>
<fpage>E999</fpage>
<lpage>E1008</lpage>
<self-uri xlink:href="pnas.201611089.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Neurons coregulate their number of synapses and the probability of neurotransmitter release per synapse in an antagonistic manner. The binding of neuronal calcium sensor 1 (NCS-1) to the guanine exchange factor protein Ric8a coregulates these neuronal features. This study identified a small molecule, the phenothiazine FD44, that binds the interaction surface between NCS-1 and Ric8a, preventing the formation of the complex. Tested on a <italic>Drosophila</italic> model of the fragile X syndrome, where the number of synapses is in excess, FD44 proves effective to reduce synapse number to normal levels and restore normal learning performance. Our structure–function study shows the specificity of this compound and the drugability of the NCS-1/Ric8a interface for the treatment of fragile X and possibly, other synaptopathies.</p>
</abstract>
<abstract>
<p>The protein complex formed by the Ca<sup>2+</sup> sensor neuronal calcium sensor 1 (NCS-1) and the guanine exchange factor protein Ric8a coregulates synapse number and probability of neurotransmitter release, emerging as a potential therapeutic target for diseases affecting synapses, such as fragile X syndrome (FXS), the most common heritable autism disorder. Using crystallographic data and the virtual screening of a chemical library, we identified a set of heterocyclic small molecules as potential inhibitors of the NCS-1/Ric8a interaction. The aminophenothiazine FD44 interferes with NCS-1/Ric8a binding, and it restores normal synapse number and associative learning in a <italic>Drosophila</italic> FXS model. The synaptic effects elicited by FD44 feeding are consistent with the genetic manipulation of NCS-1. The crystal structure of NCS-1 bound to FD44 and the structure–function studies performed with structurally close analogs explain the FD44 specificity and the mechanism of inhibition, in which the small molecule stabilizes a mobile C-terminal helix inside a hydrophobic crevice of NCS-1 to impede Ric8a interaction. Our study shows the drugability of the NCS-1/Ric8a interface and uncovers a suitable region in NCS-1 for development of additional drugs of potential use on FXS and related synaptic disorders.</p>
</abstract>
<kwd-group>
<kwd>fragile X syndrome</kwd>
<kwd>synapse regulation</kwd>
<kwd>NCS-1</kwd>
<kwd>protein–protein interaction inhibitor</kwd>
<kwd>X-ray crystallography</kwd>
</kwd-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>